|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 453/02 | (2006.01) |
| A61K 31/439 | (2006.01) | ||
| C07D 451/02 | (2006.01) |
| (11) | Number of the document | 1740177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05746609.6 |
| Date of filing the European patent application | 2005-04-27 | |
| (97) | Date of publication of the European application | 2007-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-08 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/US2005/014386 |
| Date | 2005-04-27 |
| (87) | Number | WO 2005/104745 |
| Date | 2005-11-10 |
| (30) | Number | Date | Country code |
| 565623 P | 2004-04-27 | US |
| (72) |
LAINE, Dramane, I., US
PALOVICH, Michael, R., US
MCCLELAND, Brent, W., US
NEIPP, Christopher, E., US
THOMAS, Sonia, M., US
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Muskarininių acetilcholino receptorių antagonistai |
| MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2024-03-21 | 347.00 EUR |